New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Eledon Pharmaceuticals, Inc.
ELDN
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

151M

Biotechnology

Next Earning date - 14 Nov 2024

151M

Biotechnology

Next Earning date - 14 Nov 2024

3.81USD
Shape0.45 ( 13.20%)
Market Open
favorite-chart

Relative Strenght

90
favorite-chart

Volume Buzz

13345%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

7%

Quote Panel

Shape
Updated October 29, 2024
1W 8.77 % 1M 52.45 % 3M 37.53 % 1Y 140.25 %

Key Metrics

Shape
  • Market Cap

    151.29M


  • Shares Outstanding

    39.66M


  • Share in Float

    39.63M


  • Dividende

    0


  • Earning Date

    14 Nov 2024


  • Price Target

    3.815


  • Average Volume

    67335


  • Beta

    0.883


  • Range

    1.07-4.12


  • Industry

    Biotechnology


  • Website

    https://eledon.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

238.64x

P/S Ratio

-16.76x

P/B Ratio

-0.1

Debt/Equity

-13424.5%

Net Margin

$0.5

EPS

How ELDN compares to sector?

P/E Ratio

Relative Strength

Shape

ELDN

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$33M

ShapeNaN%

2025-Revenue

$0.65

Shape39%

2025-EPS

$20M

Shape239%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.73
vs -0.66

Q4.22

arrow
arrow

N/A

-0.68
vs -0.59

Q1.23

arrow
arrow

N/A

-0.75
vs -0.69

Q2.23

arrow
arrow

N/A

-0.40
vs -0.65

Q3.23

arrow
arrow

N/A

-0.35
vs -0.73

Q4.23

arrow
arrow

N/A

-0.29
vs -0.68

Q1.24

arrow
arrow

N/A

-0.34
vs -0.75

Q2.24

arrow
arrow

N/A

-0.32
vs -0.40

Q3.24

arrow
arrow

N/A

-0.32
vs -0.35

Q4.24

arrow
arrow

N/A

-0.31
vs -0.29

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

NA

NA  vs NA

Q2.22

arrow
arrow

NA

NA  vs NA

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

-100%

NA  vs 120

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

560K  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-7%

-0.07
vs -0.06

Q4.22

arrow
arrow

-69%

-0.69
vs -0.07

Q1.23

arrow
arrow

-14%

-0.14
vs -0.69

Q2.23

arrow
arrow

-10%

-0.10
vs -0.14

Q3.23

arrow
arrow

-11%

-0.11
vs -0.10

Q4.23

arrow
arrow

-12%

-0.12
vs -0.11

Q1.24

arrow
arrow

-14%

-0.14
vs -0.12

Q2.24

arrow
arrow

+528%

5.28
vs -0.14

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

29

29
vs 29

NA

Q4.22

arrow
arrow

28

28
vs 29

-3%

Q1.23

arrow
arrow

31

31
vs 28

11%

Q2.23

arrow
arrow

33

33
vs 31

6%

Q3.23

arrow
arrow

28

28
vs 33

-15%

Q4.23

arrow
arrow

29

29
vs 28

4%

Q1.24

arrow
arrow

30

30
vs 29

3%

Q2.24

arrow
arrow

31

31
vs 30

3%

Earnings Growth

Latest News